Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Bruno Kamber"'
Publikováno v:
Tetrahedron. 49:3559-3575
The TASP (Template Assembled Synthetic Protein) concept in protein de novo design has been introduced for the construction of protein-like molecules exhibiting tailor-made functional properties. After establishing some synthetic and conformational fo
Publikováno v:
Tetrahedron. 49:9307-9320
In the synthesis of large peptides. the yield and purity of the end-products will be greatly improved when smaller segments are purified prior to their use for fragment coupling either on a solid-phase resin or in solution. The Naα-Fmoc(9-fluorenylm
Publikováno v:
Biochemical and Biophysical Research Communications. 181:1365-1371
CGP 42112A, a potent angiotensin AT2 receptor selective ligand, was radioiodinated and its binding characteristics compared with those of [125I]angiotensin II. In human myometrium (only AT2 expressed), binding was saturable (Kd 1.03 × 10−10 M; Bma
Publikováno v:
Biochemical and Biophysical Research Communications. 169:636-642
Sarmesin, [Sar1, Tyr(Me)4]angiotensinII], has been reported to be a competitive angiotensin II (AII) receptor antagonist in rat smooth muscle preparations (Scanlon et al., (1984), Life Science 34, 317-321). In the present study, sarmesin displaced AI
Autor:
Bruno Kamber, H. P. Ramjoue, M. Mele, P. J. Whitcombe, M. de Gasparo, Steven Whitebread, A. S. Motani
Publikováno v:
Journal of Cardiovascular Pharmacology. 16:S31-S35
Two angiotensin II receptor subtypes, A and B, have been described by means of specific and selective ligands (Biochem Biophys Res Commun 1989; 163:284-91). The present report describes the binding characteristics and the distribution of these subtyp
Autor:
Marc De Gasparo, Serge P. Bottari, Véronique Brechler, Pascal Furet, Bruno Kamber, Steven Whitebread, Nigel Levens
Publikováno v:
Angiotensin Receptors ISBN: 9781461360490
During the past 30 years, evidence has accumulated from pharmacological studies indicating that there are multiple subtypes of the angiotensin II (ANG II) receptor. A great many peptide analogues of ANG II have been synthesized to obtain final proof
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ee6521a427e5119eb77ac81c81089e66
https://doi.org/10.1007/978-1-4615-2464-9_5
https://doi.org/10.1007/978-1-4615-2464-9_5
Publikováno v:
Peptides 1992 ISBN: 9789401046466
Peptides 1992
Peptides 1992
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::155f8ae043577f75332fe41020fe4149
https://doi.org/10.1007/978-94-011-1470-7_28
https://doi.org/10.1007/978-94-011-1470-7_28
Autor:
Leoluca Criscione, S. Whitebread, R. H. Andreatta, Helene Thomann, Bruno Kamber, M. de Gasparo, Bernhard Riniker
Publikováno v:
Journal of receptor research. 11(1-4)
Angiotensin II [1-8 or 2-8] analogues and [4-8] fragments were dimerized through the amino- or carboxy-terminal groups in order to try to increase their potency as reported for other hormones. The binding affinity to the angiotensin II receptor subty
Autor:
F. Ostermayer, M. de Gasparo, Helene Thomann, Bruno Kamber, S. Whitebread, Peter Buehlmayer, Peter Herold, Leoluca Criscione
Publikováno v:
Journal of cardiovascular pharmacology. 16
Subtypes of angiotensin II (Ang II) receptors have been recently identified using specific ligands (see Whitebread et al. Biochem Biophys Res Comm 1989; 163:284-291). The present study compares the binding characteristics of different structural clas
Publikováno v:
Helvetica Chimica Acta. 63:2358-2363
Cystine peptides are conveniently prepared from S-acetamidomethyl- or S-trityl-protected cysteine derivatives by direct oxidation with iodine. Since the reaction proceeds through the formation of sulfenyl iodides, these highly reactive groups may sub